Hideki Fujii | Cardiovascular Researches | Best Researcher Award

Posted on by Pencis

Dr. Hideki Fujii | Cardiovascular Researches | Best Researcher Award

Dr. Hideki Fujii, Osaka Metropolitan University, Japan

Dr. Hideki Fujii is a Lecturer at the Department of Hepatobiliary and Pancreatic Diseases, Osaka Metropolitan University Graduate School of Medicine, Japan. He earned his M.D. in 1998 and Ph.D. in Anatomy in 2004 from Osaka City University. With over two decades of clinical and academic experience, his expertise lies in liver cirrhosis therapeutics and gastrointestinal diseases. He has held several key roles at Osaka City University Hospital and affiliated institutions. Dr. Fujii is recognized for his research contributions, leadership in hepatobiliary medicine, and dedication to advancing treatment approaches for chronic liver and pancreatic disorders.

AUTHOR PROFILE

Scopus Profile

Orcid Profile

🎓 EARLY ACADEMIC PURSUITS:

Dr. Hideki Fujii began his academic journey at Osaka City University Medical School, where he earned his M.D. in 1998. His strong interest in anatomical sciences led him to pursue a Ph.D. in Anatomy, which he successfully completed in 2004 at the Department of Anatomy, Osaka City University Graduate School of Medicine. These formative years laid a solid foundation for his future specialization in hepatobiliary and pancreatic diseases.

💼 PROFESSIONAL ENDEAVORS:

Dr. Fujii’s clinical and academic career spans over two decades, demonstrating a continuous commitment to gastroenterology and hepatobiliary medicine:

  • 1998–2000: Began his residency at Osaka City University Hospital and Izumi City Hospital, gaining fundamental clinical experience.

  • 2004–2007: Served as a Junior Clinical Fellow at Osaka City University Hospital.

  • 2007–2009: Promoted to Senior Clinical Fellow in the same institution.

  • 2009–2014: Became a Lecturer in the Department of Hepatobiliary and Pancreatic Diseases at Osaka City University Hospital.

  • 2014–2016: Appointed Chief Physician in the Department of Gastroenterology at Osaka City Juso Hospital, reflecting his rising leadership in clinical practice.

  • 2016–2019: Served as a Specially Appointed Lecturer at the Endowed Chair for Liver Cirrhosis Therapeutics, Osaka City University.

  • 2019–2022: Promoted to Lecturer in both the Department and Endowed Chair at Osaka City University Graduate School of Medicine.

  • 2022–present: Currently holds the position of Lecturer in the Department of Hepatobiliary and Pancreatic Diseases at Osaka Metropolitan University Graduate School of Medicine.

🧬 CONTRIBUTIONS AND RESEARCH FOCUS ON CARDIOVASCULAR RESEARCHES:

Dr. Fujii’s core research revolves around hepatobiliary and pancreatic diseases, with a specialized emphasis on liver cirrhosis therapeutics. Through his association with the Endowed Chair for Liver Cirrhosis Therapeutics, he has played a significant role in the development and advancement of treatment protocols for chronic liver conditions.

His scientific contributions include:

  • Research on the pathophysiology of liver fibrosis and cirrhosis.

  • Clinical studies addressing novel therapeutics in gastroenterology.

  • Integration of anatomical research into clinical applications for liver and pancreatic disorders.

🌍 IMPACT AND INFLUENCE:

Dr. Fujii’s expertise has contributed to:

  • Enhanced clinical guidelines in hepatology and gastroenterology.

  • Training and mentoring of young physicians and fellows in the field of liver and pancreatic medicine.

  • Collaboration with national and international medical societies, influencing therapeutic standards in Japan and beyond.

📚 ACADEMIC CITES AND SCHOLARLY INFLUENCE:

Dr. Fujii’s academic work is:

  • Frequently cited in leading journals related to hepatology and gastroenterology.

  • Part of multicenter research studies, contributing valuable clinical data and interpretations.

  • Published in both Japanese and international peer-reviewed journals, solidifying his reputation in global medical research communities.

🌐LEGACY AND FUTURE CONTRIBUTIONS:

Dr. Hideki Fujii is poised to leave a lasting legacy in the medical and academic community through:

  • Continued innovation in cirrhosis therapeutics.

  • Expanding research into pancreatic diseases and their systemic effects.

  • A commitment to teaching, mentoring, and collaborative research, ensuring the next generation of clinicians carry forward his mission of excellence in liver and pancreatic health.

🌟CONCLUSION:

Dr. Hideki Fujii is a highly respected expert in hepatobiliary and pancreatic medicine , with a career marked by dedication, innovation, and academic excellence. His extensive clinical experience and research in liver cirrhosis therapeutics have made significant contributions to improving patient care and advancing medical science. As a lecturer at Osaka Metropolitan University, he continues to inspire future medical professionals while pushing the boundaries of gastroenterology research. Dr. Fujii’s ongoing work promises to leave a lasting impact on both the academic and medical communities in Japan and beyond.

TOP NOTABLE PUBLICATIONS

Liver-derived Neuregulin1α stimulates compensatory pancreatic β cell hyperplasia in insulin resistance

Authors: T. Arai, E. Hayashi, S. Maeda, N. Kawada, N. Goda

Journal: Nature Communications

Year: 2025

Utility of Mac-2 binding protein glycosylation isomer as an excellent biomarker for the prediction of liver fibrosis, activity, and hepatocellular carcinoma onset: an expert review

Authors: Y. Kamada, Y. Sumida, H. Takahashi, E. Miyoshi, A. Nakajima

Is liver fibrosis more advanced in MetALD than in MASLD?

Authors: H. Fujii, Y. Kamada, A. Tokushige, T. Watanabe, N. Kawada

Year: 2024

Low HDL cholesterol levels in women and hypertriglyceridemia in men: predictors of MASLD onset in individuals without steatosis

Authors: T. Tsutsumi, T. Kawaguchi, H. Fujii, M.E. Rinella, Y. Sumida

Journal: Journal of Gastroenterology

Year: 2025

Accuracy of type IV collagen 7S versus Enhanced Liver Fibrosis score for diagnosing fibrosis in patients with metabolic dysfunction-associated steatotic liver disease

Authors: H. Ishiba, H. Fujii, Y. Kamada, T. Okanoue, A. Nakajima

Journal: Hepatology Communications

Year: 2024

Predictors of Immediate Deterioration of the Child-Pugh Classification From A to B After Transcatheter Arterial Chemo-Embolization for Treatment-Naive Hepatocellular Carcinoma

Authors: K. Asano, K. Kageyama, A. Yamamoto, N. Kawada, Y. Miki

Journal: Cancer Medicine

Year: 2024

Validation study of age-independent fibrosis score (Fibrosis-3 index) in patients with metabolic dysfunction-associated steatotic liver disease

Authors: K. Nouso, M. Kawanaka, H. Fujii, T. Kumada, T. Okanoue

Journal: Hepatology Research

Year: 2024

A case of secondary immune thrombocytopenia induced by atezolizumab plus bevacizumab therapy for hepatocellular carcinoma resulting in death from intracranial hemorrhage

Authors: K. Rinka, H. Fujii, A. Hagihara, M. Enomoto, N. Kawada

Journal: Nippon Shokakibyo Gakkai Zasshi

Year: 2024

Hepatitis B surface antigen glycan isomer is a predictor of the development of hepatocellular carcinoma during nucleoside/nucleotide analog therapy

Authors: R. Kozuka, M. Enomoto, Y. Yukawa-Muto, S. Uchida-Kobayashi, N. Kawada

Journal: Hepatology Research

Year: 2024

Hepatic inflammation and fibrosis are profiles related to mid-term mortality in biopsy-proven MASLD: A multicenter study in Japan

Authors: T. Tsutsumi, T. Kawaguchi, H. Fujii, A. Nakajima, T. Okanoue

Journal: Alimentary Pharmacology and Therapeutics

Year: 2024

Chunna Jin | Heart Failure | Best Researcher Award

Posted on by Pencis

Dr. Chunna Jin | Heart Failure | Best Researcher Award

Dr. Chunna Jin is the Associate Chief Physician at the Department of Cardiovascular Medicine, The Second Affiliated Hospital of Zhejiang University, China. She holds a Ph.D. in Cardiovascular Medicine from The Chinese University of Hong Kong and completed her postdoctoral fellowship at St. Francis Hospital, New York, USA. With a strong focus on ischemic heart disease, heart failure, and cardiovascular imaging, Dr. Jin combines advanced clinical expertise with cutting-edge research. She has published extensively in high-impact journals and is recognized for her international collaborations and contributions to innovative, patient-centered cardiovascular care.

AUTHOR PROFILE

Scopus Profile

🎓 EARLY ACADEMIC PURSUITS:

Dr. Chunna Jin embarked on her academic journey with a profound interest in cardiovascular health. Her early dedication to medicine led her to pursue advanced studies in one of Asia’s top medical institutions. She earned her Ph.D. in Cardiovascular Medicine from the Faculty of Medicine, The Chinese University of Hong Kong (CUHK), where she laid the foundation for her clinical expertise and scientific research. This phase of her education not only enriched her clinical understanding but also honed her analytical skills, preparing her for a dynamic career in medicine.

🏥 PROFESSIONAL ENDEAVORS:

Currently, Dr. Jin serves as an Associate Chief Physician at the Department of Cardiovascular Medicine, The Second Affiliated Hospital of Zhejiang University (ZUCC) in China. In this pivotal role, she combines her clinical acumen with innovative medical practices to deliver high-quality cardiovascular care. Her career also includes international exposure as a Postdoctoral Research Fellow at St. Francis Hospital in New York, USA, a renowned center for cardiovascular treatment and research. This experience broadened her global perspective and deepened her understanding of diverse healthcare systems.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON HEART FAILURE:

Dr. Jin’s research is focused on cardiovascular diseases, with a particular interest in ischemic heart conditions, heart failure, and minimally invasive interventions. She has contributed extensively to studies involving cardiovascular pharmacotherapy, echocardiographic techniques, and electrophysiological diagnostics. Her interdisciplinary approach integrates clinical trials, translational medicine, and patient-centered innovations, contributing to a deeper understanding of heart health at both cellular and systemic levels.

🌍 IMPACT AND INFLUENCE:

Through her work, Dr. Jin has significantly influenced both clinical practice and academic research in cardiovascular medicine. Her international collaborations and her leadership at ZUCC have helped introduce cutting-edge diagnostic and therapeutic protocols into clinical settings. She is regarded as a mentor and guide by younger professionals in the field, and she has played a vital role in enhancing healthcare standards through training and development initiatives.

📚 ACADEMIC CITES AND PUBLICATIONS:

Dr. Jin has authored and co-authored numerous peer-reviewed journal articles, case reports, and conference papers, many of which are frequently cited in cardiovascular research. Her work appears in leading journals such as the European Heart Journal, Journal of the American College of Cardiology (JACC), and Circulation. These contributions have not only gained academic recognition but also have direct clinical applications that benefit patients worldwide.

🏅 LEGACY AND FUTURE CONTRIBUTIONS:

Dr. Chunna Jin’s legacy is defined by her dedication to clinical excellence, innovative research, and global collaboration. Moving forward, she aims to pioneer personalized treatment models for cardiovascular patients, integrating genomic data and AI-driven diagnostics into mainstream medicine. Her vision includes fostering international research networks, enhancing telecardiology, and contributing to global health policy on cardiovascular disease prevention.

⭐CONCLUSION:

Dr. Chunna Jin is a trailblazing leader in cardiovascular medicine whose dedication to clinical excellence and research innovation continues to make a global impact. Her journey from prestigious academic institutions to influential hospital roles reflects her unwavering commitment to improving heart health. With a passion for mentoring, international collaboration, and advancing medical science, Dr. Jin stands as a role model for future healthcare professionals. Her ongoing efforts in precision medicine and digital healthcare promise a brighter, healthier future for cardiovascular patients worldwide. Dr. Jin’s legacy is one of compassion, expertise, and visionary progress.

TOP NOTABLE PUBLICATIONS

Association between Glycated Albumin and Adverse Outcomes in Patients with Heart Failure

  • Authors: Senmiao Chen, Guanzhong Chen, Yu Jin, Shiyu Zhu, Liangliang Jia, Chengchen Zhao, Chunna Jin, Meixiang Xiang

  • Journal: Journal of Diabetes Investigation

  • Year: 2024

First-Phase Ejection Fraction to Predict Adverse Outcomes in Patients with Heart Failure

  • Authors: Chunna Jin, Guanzhong Chen, Senmiao Chen, Hong Ma, Meixiang Xiang

  • Journal: International Journal of Cardiology

  • Year: 2024

Ikram Khan | Myocardial Infarction | Best Researcher Award

Posted on by Pencis

Dr. Ikram Khan | Myocardial Infarction | Best Researcher Award

Dr. Ikram Khan, Lanzhou University, China

Dr. Ikram Khan is a postdoctoral researcher at Lanzhou University, China, specializing in genetics and microbiology. He earned his Ph.D. in Microbiology and is currently investigating the role of microbial diversity and metabolic pathways in acute myocardial infarction. His research explores the intricate relationships between blood, gut, and oral microbiomes in cardiovascular diseases. Dr. Khan previously completed his M.Phil. and Master’s in Genetics from Hazara University, Pakistan. With multiple research projects and international scholarships to his credit, he is committed to advancing precision medicine through microbiome-based diagnostics and therapeutic strategies in cardiovascular health.

AUTHOR PROFILE

Scopus Profile

Orcid Profile

Google Scholar Profile

📘 EARLY ACADEMIC PURSUITS:

Dr. Ikram Khan began his academic journey in Genetics, earning his Master’s degree from Hazara University Mansehra, Pakistan (2012–2014) under the mentorship of Dr. Aziz-Ud-Uddin. He continued to pursue an M.Phil. in Genetics (2014–2017) at the same institution, where he conducted a pivotal study titled “Analysis of mitochondrial DNA mutation in patients with heart disease in Swat, Pakistan.” These formative years laid the groundwork for his passion in genetic and microbial underpinnings of cardiovascular diseases.

🧪 PROFESSIONAL ENDEAVORS:

Dr. Khan’s pursuit of scientific excellence led him to Lanzhou University, China, where he completed a Ph.D. in Microbiology (2018–2022). His doctoral research—“Characterization of circulating microbiome in patients with myocardial infarction at different stages”—was co-mentored by renowned scientists An Lizhi and Li Zhiqiang.

Currently, Dr. Khan is undertaking a Post-Doctorate (2023–2026) in Genetics at the same university, investigating how microbial diversity influences metabolic changes and functional disruptions in acute myocardial infarction. His research is mentored by Xie Xiaodong and Li Zhiqiang.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON MYOCARDIAL INFARCTION:

Dr. Khan’s research lies at the intersection of microbiology, genetics, and cardiovascular medicine. His central aim is to unravel the complex dynamics between the blood, gut, and oral microbiomes and their metabolic byproducts, and how these elements collectively contribute to cardiovascular disease (CVD) progression.

His work is geared toward:

  • Identifying microbial biomarkers

  • Mapping metabolic pathways involved in myocardial infarction

  • Developing precision medicine strategies for early diagnosis and personalized treatment 💉

🏅 IMPACT AND INFLUENCE:

Dr. Khan’s research has:

  • Enhanced the understanding of microbiota-metabolome interplay in myocardial infarction

  • Offered novel diagnostic perspectives for cardiovascular and periodontal diseases

  • Set the stage for microbiome-based therapeutics and risk stratification tools in CVD

His projects include:

  • Profiling of blood, fecal, and salivary metabolomes

  • Comparative microbiota studies between healthy individuals and heart disease patients

  • Mitochondrial DNA mutation analysis as a potential genetic predisposition marker

🏆 HONORS AND AWARDS:

Chinese Government Scholarship for Ph.D. studies (2018–2022)
Prime Minister’s Fee Reimbursement Award for Outstanding Postgraduates (2016)
Prime Minister’s Laptop Award for Talented Students (2015)

📚 ACADEMIC CITES:

While still in the early stages of his postdoctoral research, Dr. Khan’s Ph.D. findings have already contributed to emerging literature on circulating microbiota and metabolomic profiling in cardiovascular settings. His work is expected to garner increased citations and collaborative interest from international microbiome and cardiology research circles.

🌍 LEGACY AND FUTURE CONTRIBUTIONS:

Dr. Ikram Khan is poised to become a leading voice in the microbiome-cardiovascular research nexus. His future work is expected to:

  • Uncover microbiota-based predictors of heart disease

  • Innovate non-invasive diagnostic tools based on metabolomic signatures

  • Contribute to global precision health initiatives

  • Inspire the next generation of geneticists and microbiome scientists in Pakistan and abroad

🌟CONCLUSION:

Dr. Ikram Khan stands out as a dedicated and forward-thinking researcher in the fields of genetics and microbiology, with a strong focus on cardiovascular health. His work bridges the gap between microbial communities and human disease, offering promising insights into precision medicine. By exploring how the blood, gut, and oral microbiomes influence metabolic functions and disease progression, Dr. Khan is contributing to the future of non-invasive diagnostics and targeted treatments. His academic journey and research achievements reflect a deep commitment to scientific innovation, and his work holds great potential for impactful advancements in global healthcare.

TOP NOTABLE PUBLICATIONS

Long-term exposure to high-concentration silver nanoparticles induced toxicity, fatality, bioaccumulation, and histological alteration in fish (Cyprinus carpio)
Authors: MA Kakakhel, F Wu, W Sajjad, Q Zhang, I Khan, K Ullah, W Wang
Journal: Environmental Sciences Europe
Year: 2021

Exploring blood microbial communities and their influence on human cardiovascular disease
Authors: I Khan, I Khan, Z Jianye, Z Xiaohua, M Khan, MG Hilal, MA Kakakhel, …
Journal: Journal of Clinical Laboratory Analysis
Year: 2022

Comparison of microbial populations in the blood of patients with myocardial infarction and healthy individuals
Authors: I Khan, I Khan, MA Kakakhel, Z Xiaowei, M Ting, I Ali, Y Fei, Z Jianye, …
Journal: Frontiers in Microbiology
Year: 2022

Analysis of the blood bacterial composition of patients with acute coronary syndrome and chronic coronary syndrome
Authors: I Khan, I Khan, M Usman, Z Jianye, ZX Wei, X Ping, L Zhiqiang, A Lizhe
Journal: Frontiers in Cellular and Infection Microbiology
Year: 2022

Circulating microbiota and metabolites: Insights into cardiovascular diseases
Authors: I Khan, I Khan, M Usman, Z Xiao Wei, X Ping, S Khan, F Khan, Z Jianye, …
Journal: Journal of Clinical Laboratory Analysis
Year: 2022

Gut microbiome as a treatment in colorectal cancer
Authors: AMYW Murad Khan, Suleman Shah, Wahid Shah, Ikram Khan, Hamid Ali, Ijaz Ali, …
Journal: International Reviews of Immunology
Year: 2024

The burden of omicron variant in Pakistan: an updated review
Authors: S Khan, SH Khan, F Haider, J Malik, F Khan, I Khan, I Ullah, MA Zia, …
Journal: COVID
Year: 2022

Genetic polymorphism within the wild population of Rhynchosia himalensis Benth. ex Baker
Authors: MKU Khan, N Muhammad, N Uddin, N Ali, I Khan, R Ullah
Journal: International Journal of Biosciences
Year: 2019

Assessing oral and toothbrush microbial profiles among high-altitude individuals with and without periodontal disease: a case-control study
Authors: S Lei, I Khan, X Zhang, T Chen, X Xie, X Zheng, Z Jianye, Z Li
Journal: BMC Oral Health
Year: 2024

Insights into the blood, gut, and oral microbiomes in Chinese patients with myocardial infarction: a case-control study
Authors: I Khan, I Khan, P Xie, Y Xiaohui, S Lei, T Song, Z Li, X Xie
Journal: BMC Microbiology
Year: 2025

Yaodong Li | Electrophysiology | Best Researcher Award

Posted on by Pencis

Prof. Yaodong Li | Electrophysiology | Best Researcher Award

Prof. Yaodong Li, Department of Pacing and Electrophysiology, the First Affiliated Hospital of Xinjiang Medical University, China

Prof. Yaodong Li is a leading expert in cardiac electrophysiology at the First Affiliated Hospital of Xinjiang Medical University, China. He holds a Doctor of Medicine in Cardiology from Xinjiang Medical University and serves as Professor and Chief Physician at the Cardiovascular Disease Center. Renowned for his work in pacing and atrial fibrillation, he has received numerous national and regional awards for scientific and clinical innovation. With several projects funded by the National Natural Science Foundation of China, Prof. Li is recognized as a “Research-oriented Talent” and continues to advance cardiovascular medicine through research, clinical excellence, and education.

AUTHOR PROFILE

Scopus Profile

🎓 EARLY ACADEMIC PURSUITS:

Prof. Yaodong Li embarked on his medical journey at Xinjiang Medical University, where he pursued a Doctor of Medicine in Cardiology from September 2008 to July 2012 in Urumqi, Xinjiang. His foundational years in this esteemed institution laid the groundwork for a career deeply rooted in cardiovascular research and clinical excellence. During his academic training, he quickly distinguished himself through rigorous study and early contributions to scientific research.

📚 PROFESSIONAL ENDEAVORS:

Since August 2018, Prof. Li has served as a Professor and Chief Physician at the Cardiovascular Disease Center of Xinjiang Medical University. His professional journey reflects an upward trajectory marked by commitment to patient care, cutting-edge electrophysiological techniques, and leadership in academic medicine.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON ELECTROPHYSIOLOGY:

Prof. Li’s core expertise lies in cardiac electrophysiology, pacing, and atrial fibrillation management. He has been actively involved in national and regional scientific research projects, showcasing a strong focus on innovative treatment modalities and clinical electrophysiological advancements. His research is widely respected for its clinical relevance and technical innovation.

🏆 IMPACT AND INFLUENCE:

Prof. Li’s work has earned him numerous awards and honors, demonstrating his prominence within the national and regional cardiology communities:

  • 2008–2023: Multiple Scientific and Technological Progress Awards from Urumqi City and Xinjiang Autonomous Region

  • 2012: Awarded for Excellent Paper at the 10th National Academic Biannual Meeting of the Chinese Society of Electrophysiology and Pacing

  • 2013 & 2014: Second Prize at the Xinjiang Natural Science Awards (Ranked 2nd)

  • 2022: Recognized with the “Elite in Atrial Fibrillation Prevention and Treatment” Clinical Technology Innovation Honor

  • 2023: Swept honors at the 14th Pacing Summit Forum including:

    • First Prize for Excellent ICD Case

    • Second Prize for Leadless Excellent Case

    • Excellent Young Physician Award

🔎 ACADEMIC CITES AND RECOGNITION:

His studies have contributed significantly to Chinese cardiovascular literature, often cited in national medical conferences and publications. His rankings in award listings reflect not only quality research but also peer acknowledgment of his impact on clinical practice and knowledge dissemination.

🌟 LEGACY AND FUTURE CONTRIBUTIONS:

Prof. Yaodong Li represents the future of electrophysiology in China—a visionary in device therapy, pacing technologies, and clinical research leadership. As a “Research-oriented Talent” honored by the Chinese Research Hospital Association in 2024, he is set to:

  • Inspire a new generation of electrophysiologists

  • Spearhead multicenter research projects on atrial fibrillation and ICD innovations

  • Promote global collaborations in cardiac rhythm management

🌍CONCLUSION:

Prof. Yaodong Li stands as a distinguished figure in the field of cardiac electrophysiology, blending clinical expertise with groundbreaking research and innovation. His dedication to advancing pacing techniques and atrial fibrillation treatment has earned him national recognition, prestigious awards, and significant research funding. As a mentor, physician, and scientist, he continues to shape the future of cardiovascular care in China and beyond. With a passion for excellence and a commitment to improving patient outcomes, Prof. Li remains a true pioneer and inspiration in the world of cardiology.

TOP NOTABLE PUBLICATIONS

Title: MAPK14/AIFM2 pathway regulates mitophagy-dependent apoptosis to improve atrial fibrillation
Authors: Wang, Lu; Sang, Wanyue; Jian, Yi; …; Tang, Baopeng; Li, Yaodong
Journal: Journal of Molecular and Cellular Cardiology
Year: 2025

Title: The impact of frailty on the prognosis of chronic heart failure patients treated with cardiac resynchronization therapy defibrillator implantation
Authors: Gao, Liang; Lyu, Huasheng; Tang, Baopeng; …; Zukela, Tuerhong; Lu, Yanmei
Journal: Zhonghua Nei Ke Za Zhi (Chinese Journal of Internal Medicine)
Year: 2025

Title: Effect of renal denervation on atrial neural and structural remodeling in rats with obesity-related atrial fibrillation and its mechanism
Authors: Jian, Yi; Sang, Wanyue; Wang, Lu; …; Zhang, Xing; Li, Yaodong
Journal: Chinese Journal of Pathophysiology
Year: 2024

Title: Safety and efficacy of cardioneuroablation for vagal bradycardia in a single arm prospective study
Authors: Han, Yafan; Shao, Mingliang; Yang, Hang; …; Tang, Baopeng; Li, Yaodong
Journal: Scientific Reports
Year: 2024

Title: A case of endocardial dissection caused by Micra implantation
Authors: Zhang, Jianghua; Shang, Shuai; Dong, Zhenyu; …; Xiaokereti, Jiasuoer; Tang, Baopeng
Journal: BMC Cardiovascular Disorders
Year: 2024

Title: Strategy Optimization for a Combined Procedure in Patients With Atrial Fibrillation: The COMBINATION Randomized Clinical Trial
Authors: Du, Xianfeng; Chu, Huimin; Yang, Bing; …; Yu, Xinzhi; Chen, Xiaomin
Journal: JAMA Network Open
Year: 2024

Title: CALCOCO2 prevents AngII-induced atrial remodeling by regulating the interaction between mitophagy and mitochondrial stress
Authors: Sang, Wanyue; Yan, Xiaoji; Wang, Lu; …; Tang, Baopeng; Li, Yaodong
Journal: International Immunopharmacology
Year: 2024

Tomonori Kawamura | Cardiac Rehabilitation | Best Researcher Award

Posted on by Pencis

Dr. Tomonori Kawamura | Cardiac Rehabilitation | Best Researcher Award

Dr. Tomonori Kawamura, Morinomiya University of Medical Sciences, Kishiwadatokushukai  hospital, Japan

Dr. Tomonori Kawamura is a Lecturer at Morinomiya University of Medical Sciences and a Rehabilitation specialist at Kishiwada Tokushukai Hospital, Japan. He holds a Ph.D. in Social Medicine from Osaka University and a Master’s degree in Medical Rehabilitation Science from Kobe Gakuin University. His research focuses on postoperative rehabilitation for cardiovascular surgery patients, cardiac rehabilitation for those with multiple disabilities, and physical therapy in cardiac care. Dr. Kawamura has received multiple awards, including the Excellence Award from the Japanese Association of Cardiac Rehabilitation, and is actively involved in academic and professional organizations.

AUTHOR PROFILE

Scopus Profile

📚EARLY ACADEMIC PURSUITS:

Dr. Tomonori Kawamura’s academic journey began with a strong foundation in rehabilitation science. He earned his Bachelor of Rehabilitation Science in 2010 from the Faculty of Comprehensive Rehabilitation at Kobe Gakuin University. His passion for medical rehabilitation deepened as he pursued a Master of Medical Rehabilitation Science at the same institution, completing it in 2012. Dr. Kawamura’s dedication to furthering his knowledge in the medical field led him to the Department of Social Medicine at the Graduate School of Medicine, Osaka University, where he earned his Ph.D. in 2024. This progression in his studies showcases his commitment to the field of rehabilitation and medical sciences.

🏥PROFESSIONAL ENDEAVORS:

Dr. Kawamura has built a successful career in both clinical and academic settings. Since 2010, he has been a key member of the Department of Rehabilitation at Kishiwada Tokushukai Hospital, contributing his expertise to patients undergoing rehabilitation, particularly those recovering from cardiovascular surgery. His work in clinical rehabilitation has provided him with a deep understanding of the complexities of recovery, especially in cardiovascular patients.

In addition to his clinical role, Dr. Kawamura has been involved in academia, teaching as a part-time lecturer at Kobe Gakuin University from 2016 to 2024. In 2018, he expanded his teaching role further by becoming a part-time lecturer at Nara Rehabilitation College. His passion for education continued to grow, and in 2025, he became a full-time Lecturer at the Department of Physical Therapy at Morinomiya University of Medical Sciences. This progression in his teaching career highlights his influence on future generations of medical professionals.

🔬CONTRIBUTIONS AND RESEARCH FOCUS ON CARDIAC REHABILITATION:

Dr. Kawamura’s research is centered around improving the rehabilitation of cardiovascular surgery patients. His focus lies on the physical therapy techniques and interventions needed for effective cardiac rehabilitation, particularly for patients with multiple disabilities. His work aims to enhance recovery outcomes by developing tailored rehabilitation programs that address both the physical and psychological needs of patients.

His research interests are particularly focused on postoperative rehabilitation and how different rehabilitation methods can aid patients recovering from cardiovascular surgeries. This specialization places him at the intersection of rehabilitation and cardiology, bridging two essential areas of medicine. His research has significantly contributed to improving cardiac rehabilitation, especially for patients with complex needs.

🌟IMPACT AND INFLUENCE:

Dr. Kawamura’s work has not gone unnoticed in the medical community. In July 2023, he received the Excellence Award from the Japanese Association of Cardiac Rehabilitation, a testament to the quality and significance of his contributions to the field. His impact in the cardiovascular rehabilitation space was further recognized in March 2022 when he won the Co-medical Award Third Place from the Japanese Circulation Society. Additionally, in September 2019, he was honored with the Excellence Award from the Japanese Society of Cardiovascular Management Therapy. These accolades reflect his influence and expertise in cardiac rehabilitation and highlight the positive changes he has brought to the rehabilitation process.

📑ACADEMIC CITATIONS AND RECOGNITION:

Dr. Kawamura’s research has been widely cited by his peers and continues to shape the academic landscape of rehabilitation and cardiology. His work has been an essential resource for many medical professionals who specialize in cardiac rehabilitation, and his research papers are regularly referenced in related medical journals. The recognition he has earned within academic circles solidifies his reputation as a leader in his field.

🔮LEGACY AND FUTURE CONTRIBUTIONS:

Dr. Kawamura’s legacy is already taking shape as a mentor and educator in the medical rehabilitation field. Through his teaching roles at various institutions, he has trained and inspired numerous students who are now following in his footsteps. His contributions to cardiac rehabilitation, especially for those with multiple disabilities, have already made a lasting impact, but his future endeavors promise even more groundbreaking work.

Looking ahead, Dr. Kawamura is poised to continue making significant strides in cardiac rehabilitation. His ongoing research into effective rehabilitation strategies for cardiovascular surgery patients will likely lead to even more tailored and effective treatment protocols. As his influence grows, his future contributions have the potential to change the landscape of rehabilitation science for years to come.

🤝PROFESSIONAL AFFILIATIONS AND COMMUNITY ENGAGEMENT:

Dr. Kawamura is an active member of several professional associations, which keep him connected to the wider medical and rehabilitation community. He is affiliated with:

  • The Japanese Association of Cardiac Rehabilitation

  • The Japanese Circulation Society

  • Japanese Physical Therapy Association

  • Japanese Society of Cardiovascular Physical Therapy

  • Japanese Orthopaedic Trauma Association

These affiliations not only enable Dr. Kawamura to stay informed about the latest developments in his field but also allow him to contribute to shaping the direction of rehabilitation science and cardiac care on a national level.

🌟CONCLUSION:

Dr. Tomonori Kawamura’s academic pursuits, professional experiences, and research contributions have positioned him as a leading figure in the field of cardiac rehabilitation. His passion for advancing rehabilitation science, particularly for cardiovascular patients, has already earned him numerous awards and honors. As he continues to teach and research, his impact on the field will undoubtedly grow, leaving behind a legacy of excellence and innovation.

TOP NOTABLE PUBLICATIONS

Early achievement of walkability after cardiac surgery and the risk of cardiovascular disease after hospital discharge
Authors: T. Kawamura, R. Sakaniwa, M. Nishimura, H. Iso, T. Sobue
Journal: ESC Heart Failure
Year: 2024

Changes in cardiac sympathetic nerve activity on 123I-metaiodobenzylguanidine scintigraphy after MitraClip therapy
Authors: K. Fukuda, S. Hasegawa, T. Kawamura, et al.
Journal: ESC Heart Failure
Year: 2021

Factors related to physical functioning decline after cardiac surgery in older patients: A multicenter retrospective study
Authors: A. Itagaki, M. Saitoh, D. Okamura, T. Kawamura, et al.
Journal: Journal of Cardiology
Year: 2019

Impact of preoperative frailty on regaining walking ability in patients after cardiac surgery: Multicenter cohort study in Japan
Authors: S. Yuguchi, M. Saitoh, K. Oura, T. Kawamura, et al.
Journal: Archives of Gerontology and Geriatrics
Year: 2019

Postoperative atrial fibrillation is associated with delayed early rehabilitation after heart valve surgery: A multicenter study
Authors: M. Kato, M. Saitoh, T. Kawamura, et al.
Journal: Physical Therapy Research
Year: 2019

Mushidur Rahman | Echocardiography | Best Researcher Award

Posted on by Pencis

Dr. Mushidur Rahman | Echocardiography | Best Researcher Award

Dr. Mushidur Rahman, Coventry University, United Kingdom

Dr. Mushidur Rahman is a UK-based Clinical Cardiovascular Physiologist and PhD candidate at Coventry University. With accreditation from the British Society of Echocardiography, he specializes in advanced echocardiographic imaging and cardiac diagnostics. He holds an MSc in Translational Cardiovascular Medicine from the University of Bristol and a BSc in Cardiac Physiology. Currently an Advanced Cardiac Physiologist at Sandwell and West Birmingham Hospitals, he also lectures at Coventry University. Passionate about improving patient care through research and education, Dr. Rahman combines clinical expertise with academic insight to advance the field of cardiovascular diagnostics and healthcare quality.

AUTHOR PROFILE

Scopus Profile

Orcid Profile

👨‍🎓 EARLY ACADEMIC PURSUITS:

Dr. Mushidur Rahman’s academic journey showcases a deep-rooted passion for cardiovascular sciences. He began with a GCSE foundation at Park View School in 2008, where he excelled in subjects like Religious Studies (A) and Mathematics (B), and demonstrated broad intellectual interest across humanities and sciences.
He further pursued A-Levels and a BTEC in Applied Science at Midlands Metropolitan College (2012), achieving a Distinction-Merit in BTEC, and a solid grounding in Law, Sociology, and Psychology.

His academic focus intensified with a BSc (Hons) in Cardiac Physiology from the University of Wolverhampton in 2015, laying the clinical and scientific groundwork in cardiology. In 2019, he earned an MSc in Translational Cardiovascular Medicine from the University of Bristol, a program that bridged laboratory science with clinical applications. He is currently finalizing his Ph.D. in Clinical Cardiovascular Physiology at Coventry University, with expected completion in 2025.

🏥 PROFESSIONAL ENDEAVORS:

Dr. Rahman brings nearly a decade of clinical experience in NHS settings, blending expert-level echocardiography with leadership in cardiac services.

🔬 ADVANCED CARDIAC PHYSIOLOGIST:

Sandwell and West Birmingham Hospitals NHS Trust (2016–Present)
He has served as an Advanced Cardiac Physiologist specializing in echocardiography, while also acting as Deputy Lead in the Cardiac Catheterisation Lab. His responsibilities include:

  • Supervising and mentoring junior staff and students 👨‍⚕️

  • Conducting audits and clinical research

  • Collaborating closely with cardiologist consultants

  • Leading multidisciplinary team (MDT) meetings

  • Supporting IQIPS (Improving Quality in Physiological Services) objectives

👨‍🏫 VISITING LECTURER:

Coventry University (2022–Present)
As an academic contributor under the Associate Fellowship for Higher Education, Dr. Rahman has lectured on Cardio-Respiratory anatomy and physiology across BSc Paramedic Science and Nursing programs. He provides practical demonstrations and life support training, enriching student experiences with real-world insight.

🩺 EARLY CLINICAL EXPERIENCE:

Heart of England NHS Trust (Jan–Jul 2016)
His early role as a Cardiac Physiologist involved:

  • Performing and analyzing ECGs and exercise tolerance tests

  • Involvement in the cardiac catheter laboratory

  • Conducting pacemaker follow-up clinics

  • Participating in on-call services for cardiac emergencies

🧪 CONTRIBUTIONS AND RESEARCH FOCUS ON ECHOCARDIOGRAPHY:

Dr. Rahman’s research focuses on diagnostic cardiac imaging, echocardiographic techniques, and cardiovascular physiology. His work aims to improve:

  • Diagnostic accuracy

  • Early detection of cardiac pathologies

  • Evidence-based approaches in patient management

He is also active in clinical audits and quality improvement initiatives, tying his academic research directly to patient outcomes and healthcare efficiency.

🌍 IMPACT AND INFLUENCE:

Dr. Rahman’s dual roles in clinical practice and academia allow him to influence both current patient care and the future generation of healthcare professionals. His leadership in MDT meetings and mentorship of junior staff contribute to a collaborative and learning-centered environment.

Through public speaking, teaching, and research dissemination, he promotes a patient-centric model of care in cardiology, focused on compassion, precision, and innovation.

📚 ACADEMIC CITES & PROFESSIONAL ACCREDITATION:

  • Accredited by the British Society of Echocardiography (BSE)

  • Active contributor to clinical research publications and audits

  • Pursuing doctoral research that may contribute to peer-reviewed journals, elevating standards in diagnostic cardiology

🌟 LEGACY AND FUTURE CONTRIBUTIONS:

Dr. Rahman’s career trajectory is guided by a clear vision: to bridge the gap between academic innovation and clinical excellence in cardiovascular medicine. In the future, he aims to:

  • Publish impactful research in top cardiology journals

  • Lead national or international quality improvement programs

  • Develop training modules for cardiac physiologists and clinicians

  • Promote patient-centered care through policy and practice enhancements

His commitment to lifelong learning and multidisciplinary collaboration ensures his continued positive influence in cardiology and healthcare education.

✨CONCLUSION:

Dr. Mushidur Rahman is a dedicated cardiovascular professional, blending clinical expertise with academic pursuit. His passion for advancing cardiac diagnostics through echocardiography and clinical research is evident in his work at Sandwell and West Birmingham Hospitals and his role as a lecturer at Coventry University. Accredited by the British Society of Echocardiography, he strives to make a significant impact on patient care and healthcare quality. With a commitment to lifelong learning, Dr. Rahman is shaping the future of cardiovascular medicine through both his clinical practice and research contributions.

TOP NOTABLE PUBLICATIONS

Title: Relationship between heart rate variability and echocardiography indices of cardiac function in healthy individuals
Authors: Rahman, M., Russell, S.L., Okwose, N.C., Banerjee, P., Jakovljević, D.G.
Journal: Clinical Physiology and Functional Imaging
Year: 2025

Title: Validity and reliability of short‐term heart‐rate variability from disposable electrocardiography leads
Authors: Rahman, M.
Journal: Health Science Reports
Year: 2023

Title: Association between pulse wave velocity and measures of cardiac function in healthy individuals
Authors: Rahman, M.
Journal: Heart Journal
Year: 2022

Title: Relationship between cardiac autonomic function and novel echocardiography indices of left ventricular function
Authors: Rahman, M.
Journal: Heart Journal
Year: 2022

Title: Observations on echocardiographic findings in patients with COVID-19
Authors: Rahman, M.
Year: 2020

Jian-Jun Li | Cardiology | Best Researcher Award

Posted on by Pencis

Prof. Dr. Jian-Jun Li | Cardiology | Best Researcher Award

Prof. Dr. Jian-Jun Li, Fuwai hospital, China

Prof. Dr. Jian-Jun Li is a renowned cardiologist at Fu Wai Hospital, Chinese Academy of Medical Science, Beijing. He holds an MD from Wuhan University, a PhD from Kyushu University, Japan, and completed post-doctoral training in the USA. As Professor and Consultant at the Cardiometabolic Center, his research focuses on dyslipidemia, inflammation, atherosclerosis, and interventional cardiology. He serves as Vice President of the Chinese Molecular College of Cardiology and is a national expert in cardiovascular disease prevention. Prof. Li has received multiple prestigious science awards, recognizing his significant contributions to cardiovascular medicine and public health in China.

AUTHOR PROFILE

Scopus Profile

👨‍🎓 EARLY ACADEMIC PURSUITS:

Prof. Dr. Jian-Jun Li began his academic journey in medicine at Wuhan University, China, where he pursued his MD from 1978 to 1986. With a strong foundation in clinical and theoretical medical sciences, he furthered his education with a PhD from Kyushu University, Japan (1991–1995)—a prestigious institution known for its cutting-edge biomedical research. He then expanded his international experience through a Post-doctoral Fellowship at the University of Louisville, USA (1995–1997), where he explored advanced cardiovascular research.

👨‍⚕️ PROFESSIONAL ENDEAVORS:

Currently, Prof. Dr. Jian-Jun Li serves as a Professor and Consultant at the Cardiometabolic Center, Fu Wai Hospital, affiliated with the Chinese Academy of Medical Science and Peking Union Medical College, Beijing. This esteemed role places him at the heart of China’s most influential medical and research institution for cardiovascular health.

In addition to his primary role:

  •  He is the Vice President of the Chinese Molecular College of Cardiology.

  •  He is a Member of the National Expert Committee on Prevention and Control of Cardiovascular Disease.

  •  He is an Expert Member of the Chinese Doctor Union.

🧪 CONTRIBUTIONS AND RESEARCH FOCUS ON CARDIOLOGY:

Prof. Dr. Jian-Jun Li’s research work is both broad and impactful, focusing on some of the most critical issues in modern cardiology:

  • Dyslipidemia – studying abnormal lipid levels and their role in cardiovascular disease.

  • Inflammation and Atherosclerosis – understanding how chronic inflammation contributes to plaque buildup in arteries.

  • Interventional Cardiology – innovating and improving minimally invasive procedures to treat cardiovascular conditions.

His work bridges the gap between molecular cardiology and clinical applications, aiming for preventive and therapeutic breakthroughs in cardiovascular health.

🏆 IMPACT AND INFLUENCE:

Prof. Li’s contributions have been nationally and internationally acknowledged:

  • Secondary Awards of National Science and Technology in Advance (2002)

  • Hubei Province Awards of Chinese Science and Technology in Advance for five consecutive years: 1999–2003

These awards reflect the consistency, excellence, and innovation in his work, particularly in translational medicine and cardiovascular disease control.

📚 ACADEMIC CITES AND COLLABORATIONS:

Prof. Li has been widely cited in national and international scientific publications. His peer-reviewed research articles in leading cardiology and internal medicine journals have significantly influenced clinical practices in China and abroad. His collaborations with researchers in Japan, the USA, and Europe have expanded the global reach of Chinese cardiovascular research.

🧬 LEGACY AND FUTURE CONTRIBUTIONS:

As a visionary academic and physician, Prof. Li’s legacy is cemented in:

  •  Mentoring the next generation of cardiologists and researchers in China.

  •  Shaping policy frameworks for cardiovascular disease prevention nationwide.

  •  Advancing personalized medicine approaches in dyslipidemia and atherosclerosis.

  •  Promoting international cooperation in cardiovascular research.

His future contributions are likely to continue influencing both clinical and molecular cardiology, especially in integrative therapeutic techniques and public health strategies.

🌟CONCLUSION:

Prof. Dr. Jian-Jun Li stands as a leading figure in the field of cardiology, combining clinical expertise with groundbreaking research. His contributions to understanding and treating dyslipidemia, inflammation, and atherosclerosis have advanced both preventive and interventional cardiology in China and beyond. Through his leadership roles and active participation in national health committees, he continues to influence cardiovascular disease prevention strategies. His dedication to medical science, mentorship, and innovation ensures a lasting legacy in improving heart health. Prof. Li’s work not only enhances clinical outcomes but also inspires the next generation of medical researchers and practitioners.

TOP NOTABLE PUBLICATIONS

Article: Association of Insomnia, Lipid Profile, and Lipid-Lowering Medications: A Narrative Review

Authors: Jia, Fang; Shi, Shunyi; Fei, Sifan; Zhou, Min; Li, Jianjun

Journal: Review

Article: Moderate-Intensity Statin Plus Ezetimibe: Time to Rethink it as an Optimal Initial Lipid-Lowering Strategy

Authors: Li, Sha; Liu, Huihui; Li, Jianjun

Journal: Review

Article: Tafolecimab, a Third Monoclonal Antibody for PCSK9 as the Novel Lipid-Lowering Drug Around the World: A Narrative Review

Authors: Liu, Huihui; Li, Sha; Li, Jianjun

Journal: Review

Article: The effect of lipid-lowering therapy on lipid-related residual risk factors: a prospective study

Authors: Li, Zhifan; Gao, Yanan; Lu, Qianhong; Qiu, Hong; Wu, Naqiong; Li, Jianjun

Journal: Lipids in Health and Disease

Year: 2024

Article: The Effects of Sacubitril/Valsartan Compared to Olmesartan on the Blood Pressure and Glucolipid Metabolism in DM Patients with Primary Hypertension

Authors: Zhang, Shuang; Yin, Zheng; Li, Zhifan; Qian, Jie; Wu, Naqiong; Li, Jianjun

Journal: Cardiovascular Drugs and Therapy

Year: 2024

Article: Twin Phenomena of Hypertrophic Cardiomyopathy: A Reported Case Series

Authors: Zeng, Jiangting; Zhang, Ying’ai; Ma, Tianyi; Zhong, Jianghua; Li, Jianjun

Journal: Review

Article: Prognostic role of lipoprotein(a) in atherosclerotic cardiovascular disease risk from a perspective on current risk stratification

Authors: Li, Sha; Liu, Huihui; Zhang, Yan; Guo, Yuanlin; Li, Jianjun

Journal: MedComm

Year: 2024

Editorial: Lipids, Genetics, and the Risk of Type 2 Diabetes: More Studies Needed to Uncover the Mysteries

Author: Li, Jianjun

Journal: Editorial

Article: Prognostic value of red blood cell distribution width-to-albumin ratio in patients with stable coronary artery disease stratified by glucose metabolic status: a prospective cohort study

Authors: Liu, Huihui; Guo, Yuanlin; Zhu, Chenggang; Qian, Jie; Li, Jianjun

Journal: Cardiology Plus

Year: 2024

Article: Lipoprotein(a) and ischemic stroke: current insights and knowledge gaps

Authors: Yang, Cheng; Wu, Yongjian; Qian, Jie; Li, Jianjun

Journal: Review

Ling He | Cardiotoxicity | Best Research Article Award

Posted on by Pencis

Assoc. Prof. Dr. Ling He | Cardiotoxicity | Best Research Article Award

Assoc. Prof. Dr. Ling He, The Second Affiliated Hospital of Nanchang University, China

Assoc. Prof. Dr. Ling He is a distinguished medical professional at The Second Affiliated Hospital of Nanchang University, China. With a strong background in clinical medicine, she specializes in translational research, innovative diagnostics, and patient-centered care. As an associate professor, she actively mentors medical students and leads research projects focused on improving clinical outcomes and healthcare quality. Her work has been published in reputed journals and widely cited, reflecting her influence in the medical research community. Dr. He remains committed to advancing healthcare practices through academic excellence, collaborative research, and continuous medical innovation.

AUTHOR PROFILE

Scopus Profile

🧠 EARLY ACADEMIC PURSUITS:

Assoc. Prof. Dr. Ling He began her academic journey with a strong foundation in medical sciences, developing an early interest in clinical medicine and healthcare research. She pursued her undergraduate and postgraduate studies in prestigious medical institutions in China, eventually specializing in fields aligned with clinical diagnosis, treatment innovation, and patient-centric research. Her commitment to academic excellence and scientific rigor laid the groundwork for a promising career in medical academia and clinical research.

🩺 PROFESSIONAL ENDEAVORS:

Dr. Ling He currently serves as an Associate Professor at The Second Affiliated Hospital of Nanchang University, one of China’s reputed medical research and teaching hospitals. In her role, she is deeply involved in clinical practice, academic instruction, and mentoring young medical professionals. Her position also includes collaboration with multidisciplinary teams to improve healthcare delivery and treatment outcomes. Over the years, she has participated in numerous research projects, contributing both as a principal investigator and a collaborator.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON CARDIOTOXICITY:

Dr. Ling He’s research spans a range of clinical and biomedical sciences, focusing on:

  • Translational medicine

  • Clinical treatment protocols and their effectiveness

  • Patient safety and quality improvement in hospitals

  • Innovative diagnostic techniques

  • Public health and epidemiological studies

Her studies aim to bridge the gap between laboratory research and bedside application, ensuring that the latest scientific discoveries translate into real-world clinical improvements.

🌍 IMPACT AND INFLUENCE:

Dr. Ling He has significantly influenced both her peers and students through her mentorship, research guidance, and active involvement in academic societies. Her work has contributed to:

  • Improved clinical outcomes

  • Refined patient management protocols

  • Enhanced medical education at Nanchang University

She is frequently invited to speak at conferences and seminars, where she shares her expertise on current medical challenges and innovations. Her contributions have also helped raise the global profile of The Second Affiliated Hospital of Nanchang University in academic circles.

📚 ACADEMIC CITES:

Dr. He’s research papers have been published in national and international journals, many of which are indexed in Scopus, Web of Science, and PubMed. Her work is often cited by researchers in:

  • Clinical medicine

  • Nursing

  • Hospital management

  • Public health

This scholarly attention showcases her relevance and credibility in the academic and clinical research community.

🌟 LEGACY AND FUTURE CONTRIBUTIONS:

Assoc. Prof. Dr. Ling He is building a legacy as a thought leader in clinical medicine and hospital practice. Her future goals include:

  • Expanding international collaborations

  • Developing new models of patient-centered care

  • Training the next generation of clinicians and researchers

  • Publishing high-impact research in global medical journals

Her ongoing work is expected to shape healthcare policy, influence clinical education reforms, and enhance patient care standards both in China and beyond.

📝 OTHER IMPORTANT HIGHLIGHTS:

  • Active educator and mentor in Nanchang University’s clinical programs

  • Collaborative contributor to multi-hospital research networks

  • Advocate for innovation in healthcare systems

  • Works at the intersection of clinical practice and academic research

🌐CONCLUSION:

Assoc. Prof. Dr. Ling He stands as a dedicated and influential figure in clinical medicine and academic research. Through her role at The Second Affiliated Hospital of Nanchang University, she continues to bridge the gap between research and practice, contributing significantly to patient care and medical education. Her passion for innovation, mentorship, and collaboration is shaping the future of healthcare in China and beyond. As she advances in her career, Dr. He remains a beacon of inspiration for young professionals and a catalyst for positive change in the medical community.

TOP NOTABLE PUBLICATION

Joint assessment of abdominal obesity and non-traditional lipid parameters for primary prevention of cardiometabolic multimorbidity: insights from the China health and retirement longitudinal study 2011–2018

Authors: H. Lai, Y. Tu, C. Liao, L. He, J. Li

Journal: Cardiovascular Diabetology

Year: 2025

Sveeta Badiani | Aortic Stenosis | Best Research Article Award

Posted on by Pencis

Dr. Sveeta Badiani | Aortic Stenosis | Best Research Article Award

Xianhong Ou | Cardiovascular Pharmacology | Best Researcher Award

Posted on by Pencis

Dr. Xianhong Ou | Cardiovascular Pharmacology | Best Researcher Award